Conservative management for perimenopausal women with uterine leiomyomas using Chinese herbal medicines and synthetic analogs of gonadotropin-releasing hormone

In Vivo

Volumn 12, Issue 3, 1998, Pages 333-337

  Sakamoto, Shinobu ^a   Mitamura, Tadasu ^a   Iwasawa, Masae ^b   Kitsunai, Hideo ^b   Shindou, Kenichi ^c   Yagishita, Youichi ^c   Zhou, Ying Fang ^d   Sassa, Shuji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^c Tsumura Co Ltd   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bone loss; Gonadotropin releasing hormone analogs; Perimenopausal women; Tumor marker CA 125; Uterine leiomyoma

Indexed keywords

BUSERELIN ACETATE; CA 125 ANTIGEN; FOLLITROPIN; GONADORELIN DERIVATIVE; KEISHI BUKURYO GAN; LUTEINIZING HORMONE; NAFARELIN ACETATE; PAEONIA RADIX; TUMOR MARKER;

ADULT; ARTICLE; CHINESE MEDICINE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DEPRESSION; DYSMENORRHEA; FEMALE; FOLLITROPIN BLOOD LEVEL; HEADACHE; HERBAL MEDICINE; HOT FLUSH; HUMAN; HYPERMENORRHEA; INSOMNIA; INTRANASAL DRUG ADMINISTRATION; LUTEINIZING HORMONE BLOOD LEVEL; SWEATING; UTERUS MYOMA;

EID: 0031824771     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Jones HWJr and Joncs GS: Myoma of the Uterus. In: Novak's Textbook of Gynecology, Tenth edition (Jones HWJr and Wenta AC, eds). Baltimore, Williams and Wilkins, 1981.
2. Sakamoto S, Kudo H, Kawasaki T, Kuwa K, Kasahara N, Sassa S and Okamoto R: Effects of a Chinese herbal medicine, Keishi-bukuryogan, on the gonadal system of rats. J Ethnopharmacol 23: 151-158, 1988.
3. Imai A, Horibe S, Fuseya S, Iida K, Takagi H and Tamaya T: Possible evidence that the herbal medicine Shakuyaku-kanzo-to decreases prostaglandin levels through suppressing arachidonate turnover in endometrium. J Med 26: 163-174, 1995.
4. Sakamoto S, Yoshino H, Shirahata Y, Shimodaira K and Okamoto R: Pharmacotherapeutic effects of Keishi-bukuryo-gan on human uterine myomas. Am J Chinese Med 20: 313-317, 1992.
5. Mori T, Sakamoto S, Singtripop T, Park MK, Kato T, Kawashima S and Nagasawa H: Suppression of spontaneous development of uterine adenomyosis by a Chinese herbal medicine, Keishi-bukuryogan, in mice. Planta Med 59: 308-311, 1993.
6. Shimizu Y et al: Therapeutic effect of Keishi-bukuryo-gan on dysmenorrhea. Recent Prog KAMPO Med Obstet Gynecol 12: 72-78, 1995. (Japanese)
7. Inoue S et al: Treatment for dysmenorrhea by Shakuyaku- kanzo-to. Recent Prog KAMPO Med Obstet Gynecol 12: 65-71, 1995. (Japanese)
8. Chrisp P and GoaKL: Nafarelin. Drugs 39(4): 523-551, 1990.
9. Filicori M, Hall DA, Loughlin JS et al: A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am J Obstet Gynecol 147: 726-727, 1983.
10. Lemay A and Maheux R: GnRH agonists in the management of uterine leiomyoma. Infertil Reprod Med 7(1): 33-55, 1996.
11. El-Ahmady O, Sakr E, Khandil O, Khalifa A, Eissa S and El-Ansary T: Predictive value of tumor markers in endometrial hyperplasia and adenocarcinoma. J Tumor Marker Oncol 4(1): 71-75, 1989.
12. Maheux R and Lemay A: Uterine leiomyoma: Treatment with LHRH agonist. Prog Clin Biol Res 225: 297-311, 1986.
13. Filicori M and Flamigni C: GnRH agonists and antagonists: current clinical status. Drugs 35: 63-82, 1988.
14. Barbieri RL: Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy. Am J Obstet Gynecol 162: 593-595, 1990.
15. Monroe SE, Blumenfeld Z, Andreyko JL et al: Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin). J Clin Endocrinol Metab 63: 1334-1341, 1986.